Nippon India Pharma Fund-Growth Plan-Bonus Option
NAV as on 2026-07-17 · Equity · Sectoral/Thematic
AUM
₹9,044 Cr
1Y Return
+6.6%
3Y CAGR
+19.8%
5Y CAGR
+12.3%
Expense
1.52%
Risk
Very High
1Y Return
+6.6%
3Y CAGR
+19.8%
5Y CAGR
+12.3%
Since Inception
+17.7%
AI Fund Analysis
Get AI-powered verdict, strengths, risks, and SIP recommendations for this fund.
NAV History
Drag or scroll the chart to pan through history
52-Week NAV Range
93% from 52W low
Fund Information
Fund House
Nippon India Mutual Fund
Category
Equity - Sectoral/Thematic
Min SIP
₹500
Min Lumpsum
₹5,000
Portfolio Composition
Asset Allocation
Market Cap Split
Top Holdings
Sun Pharmaceuticals Industries Ltd
Healthcare
Lupin Ltd
Healthcare
Dr Reddy's Laboratories Ltd
Healthcare
Divi's Laboratories Ltd
Healthcare
Cipla Ltd
Healthcare
Apollo Hospitals Enterprise Ltd
Healthcare
Medplus Health Services Ltd
Healthcare
Vijaya Diagnostic Centre Ltd
Healthcare
Sai Life Sciences Ltd
Healthcare
Ajanta Pharma Ltd
Healthcare
Sector Allocation
Fundamentals
P/E Ratio
38.20
Cat avg: 42.00
P/B Ratio
5.65
Cat avg: 5.97
Dividend Yield
0.76%
Cat avg: 0.61%
Price/Sale
5.19
Price/Cash Flow
27.43
Risk Metrics (3Y)
Sharpe Ratio
0.91
Cat avg: 0.98
Sortino Ratio
1.53
Cat avg: 1.71
Beta
0.89
Cat avg: 0.95
Std Deviation
15.22%
Cat avg: 16.29%
Peer Comparison
| Fund | AUM (Cr) | Exp % | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| Nippon India Pharma Bns | 9,044 | 1.52 | +6.6% | +19.8% | +12.3% |
| Nippon India Pharma IDCW-P | 9,044 | 1.52 | +6.0% | +18.9% | +12.8% |
| ICICI Pru Pharma Healthcare Dg IDCW-P | 6,625 | 1.55 | +5.6% | +23.7% | +14.9% |
| SBI Healthcare Opportunities Reg IDCW-P | 4,998 | 1.88 | +13.6% | +23.4% | +16.2% |
| DSP Healthcare Fund Reg IDCW-P | 3,514 | 1.66 | +8.7% | +21.1% | +14.0% |
| Mirae Asset Healthcare Reg IDCW-P | 3,253 | 1.66 | +10.9% | +21.9% | +12.8% |
| HDFC Pharma and Healthcare Reg IDCW-P | 2,611 | 2.16 | +17.9% | - | - |
| Tata India Pharma & Healthcare RegIDCW-P | 1,455 | 1.84 | +6.5% | +20.7% | +13.1% |
| UTI Healthcare Reg IDCW-P | 1,308 | 2.26 | +11.6% | +25.2% | +14.2% |
| Aditya BSL Pharma & Hlthcare Reg IDCW-P | 1,011 | 1.92 | +13.0% | +21.5% | +12.5% |
What If I Had Invested?
NAV history not available for this range
Key Metrics
Risk-o-Meter
Low
Moderate
High
Very High
Rated as Very High risk
Disclaimer: Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. NAV data sourced from AMFI. This is not SEBI-registered investment advice.